Panobinostat is used in combination with the anti-cancer drug bortezomib and the corticoid dexamethasone for the treatment of multiple myeloma in adults who had received at least two previous treatments, including bortezomib and an immunomodulatory agent. It is a drug by Novartis for the treatment of various cancers.Reference standards of Panobinostat API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Panobinostat - API Standards [catalogue_number] => PA 43 85000 [category_ids] => ,80,71,81,78,70,82, [chemical_name] => [weight] => 349.43 [form] => C21H23N3O2 [cas] => 404950-80-7 [pslug] => 404950-80-7-panobinostat-api-pa4385000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => 8 [offers_name] => Ready Stock [offers_status] => 1 [offers_start_date] => 2024-12-16 [offers_end_date] => 2024-12-31 [pageview] => 2 [offers_slug] => ready-stock [offers_product_id] => 48357 [offers_product_code] => PA 43 85000 [offers_master_id] => 8 [offer_percentage] => 20 % OFF [offers_product_main_cat] => Pharmaceutical Reference Standards )
Catalogue No.:PA 43 85000
CAS :
Molecular Formula : C21H23N3O2
Molecular Weight : 349.43
stdClass Object ( [pname] => Panobinostat-d8 (Major) Hydrochloride Salt [catalogue_number] => PA STI 071360 [category_ids] => ,80,71,81,98,78,70,82, [chemical_name] => [weight] => 393.94 [form] => C21H16D8ClN3O2 [cas] => NA [pslug] => panobinostat-d8-major-hydrochloride-salt-pasti071360 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA STI 071360
Molecular Formula : C21H16D8ClN3O2
Molecular Weight : 393.94
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
